Paul Tsivitse
Pulmonary Disease · Akron, OHNPI 1083602262
Payments from drug & device makers
Across 191 payments — averaging $18.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- AstraZeneca$446
- Genentech USA, Inc.$340
- Boehringer Ingelheim$306
- United Therapeutics Corporation$147
- Inspire Medical Systems, Inc.$132
- plus $933 from 23 others
What the payments were for
- Food & beverage$3,446100%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 81 | $1,146 |
| AstraZeneca | 27 | $446 |
| Genentech USA, Inc. | 9 | $340 |
| Boehringer Ingelheim | 20 | $306 |
| United Therapeutics Corporation | 4 | $147 |
| Inspire Medical Systems, Inc. | 1 | $132 |
| Sanofi | 6 | $123 |
| Insmed, Inc. | 5 | $99 |
| Novartis | 5 | $96 |
| Amgen | 5 | $89 |
| Mallinckrodt Hospital Products Inc. | 4 | $80 |
| Actelion Pharmaceuticals US, Inc. | 3 | $62 |
| Electromed, Inc. | 3 | $40 |
| Bayer | 2 | $34 |
| UCB, Inc. | 1 | $33 |
| Johnson & Johnson | 1 | $26 |
| Pfizer | 2 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Sunovion Pharmaceuticals Inc. | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Baxter Healthcare | 1 | $18 |
| Advanced Respiratory, Inc | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $17 |
| AbbVie | 1 | $16 |
| Mylan Specialty L.p. | 1 | $15 |
| Philips North America LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,451 in reported general payments places this provider in the 55th percentile of 571 pulmonary disease providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 26 | $273,389 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 71 | $64,313 |
| Spiriva RespimatTiotropium Bromide | 28 | $16,416 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 21 | $9,922 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $2,858 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 73 | $2,040 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 11 | $529 |
| Finasteride | 11 | $313 |
| Simvastatin | 12 | $251 |
| Azelastine Hcl | 12 | $173 |
| Montelukast Sodium | 11 | $54 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimOfev, Spiriva Respimat | $306 | $289,80654 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $1,146 | $74,23592 claims |
| AstraZenecaSymbicort | $446 | $2,85812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 571 pulmonary disease providers in Ohio.
Other pulmonary disease in Akron
- Joseph KhabbazaAkron$655K
- Mohammad KhanAkron$388K
- Anthony CucciAkron$264K
- Bruce CorserCincinnati$8.2M
- Edward CordascoColumbus$8M
- Kristin HighlandCleveland$3.2M
- Brian ZenoColumbus$2.9M
- Jean ElwingCincinnati$2.4M
- Roy St JohnColumbus$1.9M
- Nishant GuptaCincinnati$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.